UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 494

Sortiert nach

Health-Related Social Needs in Patients With Gastroparesis: Relationships to Symptom Severity and Quality of Life

Gastro hep advances, 2024, Vol.3 (1), p.48-54

2024

Volltextzugriff (PDF)

Proximal and distal intragastric meal distribution during gastric emptying scintigraphy: Relationships to symptoms of gastroparesis

Neurogastroenterology and motility, 2022-12, Vol.34 (12), p.e14436-n/a

2022

Volltextzugriff (PDF)

Hair Loss in Patients with Gastroparesis: A Sign of Nutritional Deficiency in Gastroparesis?

Digestive diseases and sciences, 2023-04, Vol.68 (4), p.1397-1402

2023

Volltextzugriff (PDF)

Gastric half emptying time (T½) for 4‐h gastric emptying scintigraphy simplifies reporting but reduces detection of gastroparesis

Neurogastroenterology and motility, 2022-05, Vol.34 (5), p.e14261-n/a

2022

Volltextzugriff (PDF)

Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion

European journal of pharmacology, 2001-03, Vol.416 (3), p.213-221

2001

Volltextzugriff (PDF)

5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase

Journal of medicinal chemistry, 1994-08, Vol.37 (17), p.2627-2629

1994

Volltextzugriff (PDF)

Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate

European journal of pharmacology, 2000-07, Vol.400 (2), p.145-153

2000

Volltextzugriff (PDF)

Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle

Journal of cardiovascular pharmacology, 1989-04, Vol.13 (4), p.530-540

1989

Volltextzugriff (PDF)

Inhibition of Low Km Cyclic GMP Phosphodiesterases and Potentiation of Guanylate Cyclase Activators by Cicletanine

Journal of cardiovascular pharmacology, 1990-09, Vol.16 (3), p.501-505

1990

Volltextzugriff (PDF)

Interaction of the β Adrenergic Receptor Antagonist Bucindolol with Serotonergic Receptors

Journal of cardiovascular pharmacology, 2000-01, Vol.35 (1), p.29-36

2000

Volltextzugriff (PDF)

Differential Vasorelaxant Effects of Milrinone and Amrinone on Contractile Responses of Canine Coronary, Cerebral, and Renal Arteries

Journal of cardiovascular pharmacology, 1989-02, Vol.13 (2), p.238-244

1989

Volltextzugriff (PDF)

Heparinase III limits rat arterial smooth muscle cell proliferation in vitro and in vivo

European journal of pharmacology, 1998-06, Vol.351 (1), p.79-83

1998

Volltextzugriff (PDF)

Orally Bioavailable Benzisothiazolone Inhibitors of Human Leukocyte Elastase

Journal of medicinal chemistry, 1995-03, Vol.38 (5), p.739-744

1995

Volltextzugriff (PDF)

Identification of a Specific Radioligand for the Cardiac Rapidly Activating Delayed Rectifier K+ Channel

Circulation research, 1993-03, Vol.72 (3), p.707-714

1993

Volltextzugriff (PDF)

Novel and Potent Adenosine 3',5'-Cyclic Phosphate Phosphodiesterase III Inhibitors: Thiazolo[4,5-b][1,6]naphthyridin-2-ones

Journal of medicinal chemistry, 1995-07, Vol.38 (14), p.2546-2550

1995

Volltextzugriff (PDF)

Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle

European journal of pharmacology, 1988-05, Vol.150 (1), p.85-94

1988

Volltextzugriff (PDF)

Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5

European journal of pharmacology, 1998-05, Vol.349 (2), p.263-268

1998

Volltextzugriff (PDF)

Neutralase ™ Reverses the Anti-coagulant but Not the Anti-thrombotic Activity of Heparin in a Rabbit Model of Venous Thrombosis

Thrombosis research, 1998-08, Vol.91 (3), p.143-150

1998

Volltextzugriff (PDF)

Synthetic Heparin Pentasaccharide Depolymerization by Heparinase 1: Molecular and Biological Implications

Clinical and applied thrombosis/hemostasis, 2001-01, Vol.7 (1), p.58-64

2001

Volltextzugriff (PDF)

Protein Kinase Inhibitors and Blood Pressure Control in Spontaneously Hypertensive Rats

Hypertension (Dallas, Tex. 1979), 1991-01, Vol.17 (1), p.91-100

1991

Volltextzugriff (PDF)

Tetrahydropyrrolo[1,2-a]quinoxalines and tetrahydropyrrolo[1,2-a]pyrido[3,2-a]pyrazines: vascular smooth muscle relaxants and antihypertensive agents

Journal of medicinal chemistry, 1984-12, Vol.27 (12), p.1743-1746

1984

Volltextzugriff (PDF)

Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones

Journal of medicinal chemistry, 1992-12, Vol.35 (26), p.4858-4865

1992

Volltextzugriff (PDF)

4,5-Dihydro-3-(methanesulfonamidophenyl)-1-phenyl-1H-2,4-benzodiazepines: A Novel Class III Antiarrhythmic Agents

Journal of medicinal chemistry, 1995-07, Vol.38 (14), p.2551-2556

1995

Volltextzugriff (PDF)

Pharmacological Modulation of Cardiac and Vascular Contractile Protein Function

Journal of cardiovascular pharmacology, 1986-11, Vol.8 Suppl 9, p.S30-46

Silver, Paul J

1986

Volltextzugriff (PDF)

Species-Dependent Pharmacodynamic Effects of the Selective Low Km Cyclic AMP Phosphodiesterase III Inhibitors WIN 58993 and WIN 62005

Journal of cardiovascular pharmacology, 1995-01, Vol.25 (1), p.14-21

1995

Volltextzugriff (PDF)

1 – 25 von 494

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(434)
Mit Volltextzugriff
(429)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Health-Related Social Needs in Patients With Gastroparesis: Relationships to Symptom Severity and Quality of Life

Proximal and distal intragastric meal distribution during gastric emptying scintigraphy: Relationships to symptoms of gastroparesis

Hair Loss in Patients with Gastroparesis: A Sign of Nutritional Deficiency in Gastroparesis?

Gastric half emptying time (T½) for 4‐h gastric emptying scintigraphy simplifies reporting but reduces detection of gastroparesis

Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion

5,7-Dimethoxy-3-(4-Pyridinyl)Quinoline Is a Potent and Selective Inhibitor of Human Vascular .beta.-Type Platelet-Derived Growth Factor Receptor Tyrosine Kinase

Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate

Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle

Inhibition of Low Km Cyclic GMP Phosphodiesterases and Potentiation of Guanylate Cyclase Activators by Cicletanine

Interaction of the β Adrenergic Receptor Antagonist Bucindolol with Serotonergic Receptors

Differential Vasorelaxant Effects of Milrinone and Amrinone on Contractile Responses of Canine Coronary, Cerebral, and Renal Arteries

Heparinase III limits rat arterial smooth muscle cell proliferation in vitro and in vivo

Orally Bioavailable Benzisothiazolone Inhibitors of Human Leukocyte Elastase

Identification of a Specific Radioligand for the Cardiac Rapidly Activating Delayed Rectifier K+ Channel

Novel and Potent Adenosine 3',5'-Cyclic Phosphate Phosphodiesterase III Inhibitors: Thiazolo[4,5-b][1,6]naphthyridin-2-ones

Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle

Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5

Neutralase ™ Reverses the Anti-coagulant but Not the Anti-thrombotic Activity of Heparin in a Rabbit Model of Venous Thrombosis

Synthetic Heparin Pentasaccharide Depolymerization by Heparinase 1: Molecular and Biological Implications

Protein Kinase Inhibitors and Blood Pressure Control in Spontaneously Hypertensive Rats

Tetrahydropyrrolo[1,2-a]quinoxalines and tetrahydropyrrolo[1,2-a]pyrido[3,2-a]pyrazines: vascular smooth muscle relaxants and antihypertensive agents

Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones

4,5-Dihydro-3-(methanesulfonamidophenyl)-1-phenyl-1H-2,4-benzodiazepines: A Novel Class III Antiarrhythmic Agents

Pharmacological Modulation of Cardiac and Vascular Contractile Protein Function

Species-Dependent Pharmacodynamic Effects of the Selective Low Km Cyclic AMP Phosphodiesterase III Inhibitors WIN 58993 and WIN 62005

Suchergebnisse filtern